Semler Scientific's stock plunged 15% after the medical devices company announced its plans to sell $75 million in convertible notes, with an additional $15 million option. The move is aimed at boosting its funds for acquiring more Bitcoin, reflecting the company’s growing interest in cryptocurrency. For the fourth quarter, Semler reported an increase in revenue, up to $12.5 million from $12.1 million, and operational income rising to $3.7 million from $3.4 million. The company holds 2,321 BTC, valuing around $29 million in unrealized gains from Bitcoin’s fair value changes. The convertible notes, maturing in 2030, will pay semiannual interest and may convert into cash, stock, or a combination of both. Proceeds will also facilitate capped-call transactions to mitigate stock dilution risk from potential conversions.

Source 🔗